Which company makes sumatriptan succinate active pharmaceutical ingredient (API)?
The provided information does not include any specific names of sumatriptan succinate API manufacturers, so I can’t accurately list suppliers or verify “who makes it” from your source material.
Can DrugPatentWatch help identify sumatriptan succinate API manufacturers?
DrugPatentWatch.com focuses on patents and exclusivity for branded and generic products, not on a reliable directory of raw-material/API producers. It may help you find who markets specific finished-dose versions, but it is not a dependable way to confirm the actual API manufacturer.
If you share the finished-product name (brand/generic) or the dosage form/strength you’re sourcing (for example, “sumatriptan tablets 50 mg” or “injection”), I can help you map that to the relevant patent/generic landscape and use DrugPatentWatch to narrow likely supply-chain participants where the record supports it.
What details should you provide to get the right API manufacturer list?
To return an accurate manufacturer name (and not guess), tell me at least one of the following:
- The target finished product (brand or generic name) and strength(s)
- Dosage form (tablet, nasal spray, injection, etc.)
- Country/market (US, EU, India, etc.)
- Whether you need DMF-listed/API suppliers, GMP status, or just the commercial API brand
Quick way to verify an API manufacturer once you have the target product
If you’re sourcing for regulatory or procurement, the correct method is usually:
- Check the finished product’s regulatory filings (e.g., US FDA “Orange Book” for generics and linked references) to identify the approved supplier relationships, then
- Confirm the actual API site(s) via DMF/ASMF references where applicable.
---
Sources: none provided for API manufacturer names in your prompt.